MTC-GemcitabineAlternative Names: Gemcitabine - FeRx; Gemcitabine-MTC; Magnetic Targeted Carrier - gemcitabine
Latest Information Update: 10 Dec 2007
At a glance
- Originator FeRx
- Class Antineoplastics; Deoxyribonucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action DNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pancreatic cancer
Most Recent Events
- 04 Nov 2003 Preclinical trials in Pancreatic cancer in USA (Intra-arterial)